Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-8,314
Closed -$233K 133
2024
Q2
$233K Sell
8,314
-750
-8% -$20.6K 0.05% 109
2024
Q1
$252K Sell
9,064
-2,955
-25% -$82K 0.06% 104
2023
Q4
$346K Buy
12,019
+1,202
+11% +$36.3K 0.08% 86
2023
Q3
$359K Buy
10,817
+1,238
+13% +$43.8K 0.09% 77
2023
Q2
$351K Sell
9,579
-231
-2% -$8.99K 0.08% 82
2023
Q1
$400K Buy
9,810
+293
+3% +$12.7K 0.09% 74
2022
Q4
$488K Sell
9,517
-3,270
-26% -$157K 0.11% 66
2022
Q3
$559K Sell
12,787
-8,843
-41% -$430K 0.13% 61
2022
Q2
$1.13M Sell
21,630
-21,951
-50% -$1.12M 0.22% 44
2022
Q1
$2.26M Sell
43,581
-1,966
-4% -$102K 0.31% 38
2021
Q4
$2.69M Sell
45,547
-1,117
-2% -$55.3K 0.36% 35
2021
Q3
$2.01M Sell
46,664
-4,112
-8% -$182K 0.28% 47
2021
Q2
$1.99M Sell
50,776
-808
-2% -$31.4K 0.31% 45
2021
Q1
$1.87M Sell
51,584
-2,523
-5% -$89.6K 0.31% 45
2020
Q4
$1.99M Buy
54,107
+45,211
+508% +$1.66M 0.34% 38
2020
Q3
$309K Sell
8,896
-458
-5% -$16.1K 0.12% 70
2020
Q2
$290K Buy
+9,354
New +$318K 0.12% 78

Other funds holding PFE

Sunflower Bank's PFE Position: Q3 2024 in Review

Sunflower Bank sold out of Pfizer (PFE) in Q3 2024, closing a stake of 8,314 shares — an estimated $233K sold.

Sunflower Bank first reported a position in PFE in Q2 2020 and held it in 17 quarters. The position peaked at $2.69M in Q4 2021. 2,909 funds tracked by Wall St. Rank hold PFE as of Q3 2024.

  • Sunflower Bank reported no remaining Pfizer position as of Q3 2024 after selling out during the quarter.
  • Sunflower Bank sold 8,314 Pfizer shares in Q3 2024, an estimated $233K.
  • Sunflower Bank first reported a position in Pfizer in Q2 2020 and held it in 17 quarters.
  • Sunflower Bank's Pfizer position peaked at $2.69M in Q4 2021.
  • 2,909 funds tracked by Wall St. Rank held Pfizer as of Q3 2024.

Based on Sunflower Bank's 13F filing for Q3 2024, filed 11 Oct 2024.